A Study of Navicixizumab in Patients With Platinum Resistant Ovarian Cancer
Clinical trial NCT05043402 · UNKNOWN
Trial details
- NCT number
- NCT05043402
- Sponsor
- OncXerna Theraputics, Inc.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-30
- Primary completion
- 2023-11-15
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.